• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
46 results

SARS-COV-2-BINDING PEPTIDE

Docket 18/29,185, U.S. Patent Application (March 29, 2023)

cite Cite Docket
Analyze

M3YT56YLWFYGX55

Document SARS-COV-2-BINDING PEPTIDE, 18/29,185, No. M3YT56YLWFYGX55 (U.S. Pat. App. Nov. 26, 2024)

cite Cite Document
Analyze

Information Disclosure Statement (IDS) Form (SB08)

Document SARS-COV-2-BINDING PEPTIDE, 18/29,185, No. M3YT56YKWFYGX55 (U.S. Pat. App. Nov. 26, 2024)
Univ Nanjing Medical 23613655.1 Considered Examiner Signature Date *EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609.
2 See Kinds Codes of USPTO Patent Documents at www.uspto.gov or MPEP 901.04.
* Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3).
* For Japanese patent documents,the indication of the year of the reign of the Emperor must precede the serial numberof the patent document.
® Applicant is to place a check mark here if English language Translation is attached.
cite Cite Document
Analyze

M3YT56YHWFYGX55

Document SARS-COV-2-BINDING PEPTIDE, 18/29,185, No. M3YT56YHWFYGX55 (U.S. Pat. App. Nov. 26, 2024)

cite Cite Document
Analyze

​Letter specifying the conditions for filing under 37 CFR 1.97​

Document SARS-COV-2-BINDING PEPTIDE, 18/29,185, No. M3YT56YRWFYGX55 (U.S. Pat. App. Nov. 26, 2024)
Log in to see more
cite Cite Document
Analyze

M3YT56YIWFYGX55

Document SARS-COV-2-BINDING PEPTIDE, 18/29,185, No. M3YT56YIWFYGX55 (U.S. Pat. App. Nov. 26, 2024)

cite Cite Document
Analyze

LMOZJREHXBLUEX0

Document SARS-COV-2-BINDING PEPTIDE, 18/29,185, No. LMOZJREHXBLUEX0 (U.S. Pat. App. Sep. 18, 2023)

cite Cite Document
Analyze

Request for Corrected Filing Receipt

Document SARS-COV-2-BINDING PEPTIDE, 18/29,185, No. LMOZJS16XBLUEX2 (U.S. Pat. App. Sep. 18, 2023)
Log in to see more
cite Cite Document
Analyze
1 2 3 4 >>